Researchers Discover a Cause of Leptin Resistance—and How to Reverse It | Newswise

Are GLP-1s the First True Longevity Drug? | Newswise

Newswise — With GLP-1 drugs dominating headlines for their impact on weight loss and metabolic health, new discussions around their potential role in extending healthy lifespan are emerging. Dr. Christoph Westphal, Co-founder and General Partner of Longwood Fund, and Dr. Jarod Rutledge, Biomarkers Lead at the Amaranth Foundation, highlight why GLP-1s could be the first…

Read More
Researchers Discover a Cause of Leptin Resistance—and How to Reverse It | Newswise

Tip Sheet: New Treatments for Graft-vs.-Host Disease, Updated Dosage for HPV Vaccines — and Fred Hutch Announces Awards for Graduate Students | Newswise

Newswise — SEATTLE — March 5, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. March is the awareness month for colorectal cancer and multiple myeloma. Reach out to [email protected] if you’re looking for experts. Clinical research Novel regimen greatly reduced chronic GVHD in phase 2…

Read More
AI Meets Mental Health: Wi-Fi–Based Depression Detection for Aging Populations | Newswise

AI Meets Mental Health: Wi-Fi–Based Depression Detection for Aging Populations | Newswise

Newswise — (Toronto, March 4, 2025) A new study published in JMIR Aging developed and tested an innovative artificial intelligence (AI) model called HOPE that uses Wi-Fi–based motion sensor data to detect depression in older adults. This study offers a nonintrusive alternative to wearable devices, improving accessibility and compliance among aging populations. The research, titled “Development…

Read More
Hackensack Meridian Health Expands Lung Cancer Screenings in New Jersey through Critical Grant from Genentech | Newswise

Hackensack Meridian Health Expands Lung Cancer Screenings in New Jersey through Critical Grant from Genentech | Newswise

Newswise — February 21, 2025, Nutley, NJ – A Hackensack Meridian Health researcher and her team will partner with community groups to increase lung-cancer screening in two counties – and potentially save lives – among underserved populations.  The two-year, $750,000 Genentech Health Equity Innovation Grant was awarded to Lisa Carter-Bawa, Ph.D., MPH, APRN, ANP-C, FAAN,…

Read More